RPG Life Sciences Ltd.

₹2,698.6

-84.1 (-3%)

RPGLIFE Share Price

Pharmaceuticals & Biotechnology

As on September 11, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 4,459 Cr

P/E Ratio38.75

Dividend Yield0.11 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	2,753.86	Bearish
10-DMA	2,692.77	Bullish
20-DMA	2,661.83	Bullish
50-DMA	2,730.25	Bearish
100-DMA	2,490.52	Bullish
200-DMA	2,285.72	Bullish

Historical Performance

1 Year

12.9%

3 Years

114.7%

5 Years

341.6%

10 Years

445.2%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025
Net Sales	7,075	6,534
Total Expenditure	5,596	4,945
Other Income	256	143
Operating Profit	1,736	1,733
Interest	18	16
Depreciation	215	214
Profit Before Tax	1,542	2,329
Consolidated Net Profit	1,152	1,832
Adjusted EPS	70	111

Compounded Sales Growth

10 Years:1.6

5 Years:1.6

3 Years:1.6

TTM:1.6

Compounded Profit Growth

10 Years:-8.9

5 Years:-8.9

3 Years:-8.9

TTM:-8.9

Stock Price CAGR

10 Years:18.5

5 Years:34.5

3 Years:28.6

TTM:13.4

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:N/A

last year:69.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025
Share Capital	132	132
Total Reserves	5,921	5,173
Long-Term Borrowings	---	---
Total Non-Current Liabilities	272	64
Other Current Liabilities	330	243
Short Term Borrowings	---	---
Total Liabilities	7,932	6,568
Capital Work in Progress	200	40
Long Term Loans & Advances	128	27
Currents Investments	839	1,259
Short Term Loans and Advances	279	99
Total Current Assets	5,595	4,652
Total Assets	7,932	6,568
Adjusted Book Value	366	321

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 38.75, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 28.6%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹1736 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹7075 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1150004.3

No. of Shares: 426 (Approx)

Performance:15%

150004.3

NIFTY Performance: -6.8%

1 day Top Gainers